Select Page

Our Response to COVID-19

The COVID-19 or coronavirus pandemic has brought businesses, institutions and regular life to a halt across the world. As an essential service provider, we are committed to be a responsible partner to our communities and continue to contribute towards the advancement of clinical research and drug development. Early in March 2020, at the start of the pandemic, BioPharma recognized the impact the disease would have globally and offered to donate its clinical facilities and resources to pharmaceutical companies working on a COVID-19 vaccine.

Best Practice Procedures

We have also been quick to respond and restructure our operations in the following months to mitigate any risks. As always, our research facilities adhere to best practice guidelines recommended by Health Canada and the US Food and Drug Administration.

Since the start of the pandemic, BioPharma has finalized and released multiple SOPs to govern our operating procedures under the new COVID-19 norm. Our operations in Toronto have been classified as an essential research service by our Government Member of Parliament and continues to operate under this distinction regardless of provincial lockdowns and/or restrictions.  We continue to enforce our in-house COVID-19 procedures for all staff, subjects and guests to our facility which include (but not limited) to the following:

  • Pre-screening questionnaire and thermal temperature scan
  • Cleaning and disinfecting protocols
  • Hand hygiene and access to sanitizing solutions
  • Personal protective equipment (face shields, masks and gloves) including universal masking while on site
  • Social and physical distancing protocols in all areas of our facilities

Safety – Our First Priority

To date, both BioPharma’s sites in Toronto and St. Louis have not reported any community spread or outbreak of the COVID-19 virus. In fact, our Toronto site has been found by Canada’s largest local public health agency to have safety measures that are “above and beyond” government protocols.

The safety of our colleagues, volunteers, sponsors and community will always be our top priority.

A message from our CEO https://www.biopharmaservices.com/news/a-message-from-our-chief-executive-officer-renzo-dicarlo/

Contact Us

If you’re a volunteer, concerned about taking part in a trial during the pandemic, please contact us so we can answer your questions. We are taking proactive measures to create a safe environment in all our clinics. Click here to see what we’ve done to prioritise your safety.

If you’re a sponsor with questions about trial execution, please contact us by completing the form below to review our protocols and safety record.

“The safety of our staff, their families, our volunteers, clients and the wider community is always a top priority at BioPharma Services. This pandemic has really demonstrated how the standards that we uphold every day contribute to BioPharma being an essential service. Our cross-functional COVID task force and rigorous standard operating procedures have ensured that we have been able to continually meet and exceed client expectations despite the challenges of recent times. I’m so proud of the way this team has come together during this highly dynamic period, exhibiting not just an unwavering commitment to our stakeholders, but also an unparalleled willingness to engage and support our communities every day.”

 
Renzo DiCarlo, CEO

Schedule a Discovery
Call Today

Complete the form to schedule a Discovery Call with one of our medical experts to learn how BioPharma Services can be your trusted clinical trial partner.

[]
1 Step 1
First Nameyour first name
Last Nameyour last name
Titleyour title
Phone
Website
Company
Your Inquiry
0 /
reCaptcha v3
keyboard_arrow_leftPrevious
Nextkeyboard_arrow_right
FormCraft - WordPress form builder